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We are pleased to announce the publication of this special
issue in the journal “Clinical and Developmental Immunol-
ogy.” We are happy to perceive the growing interest, from a
wide range of scientists, regarding the peculiar intercommu-
nication between the immune system and the central nervous
system (CNS). We have finally reached a balanced compila-
tion of papers that we collect in this special issue highlighting
recent fundamental advances in our understanding of brain
immunology with an emphasis on new therapeutic targets
covering such emerging topics as chemical suppression of
glial activation, inflammation following acute demylination,
Notch signalling as a potential therapeutic target in EAE and
a link between neuroinflammatory signaling and reproduc-
tion.
The idea that the CNS is an immune-privileged site is gra-
dually vanishing. However, increasing evidence shows that
the relation between the CNS and the immune system is
special and in many aspects, different from the rest of the
organs and tissues [1].
One of the peculiarities of the CNS is the presence of
glial cells, which are the initial responders to brain injur-
ies and degenerative processes [2]. Glial cells, especially mic-
roglia, get locally activated in the damaged brain areas and
are able to induce the recruitment of scavenger blood cells,
such as monocytes and lymphocytes to injured sites, contri-
buting to the inflammatory reaction [3, 4]. In our special
issue, R. A. Taylor and L. H. Sansing, describe, in a compre-
hensive review, the role of microglial cells in ischemic stroke
and intracerebral hemorrhage. Importantly, authors high-
light the distinct phenotypes of microglia, M1-inflammatory,
and M2-repairing microglia, which express different surface
molecules and releasing factors. They propose that under-
standing the mechanism of this switching phenotype will be
crucial for future therapeutic purposes. In line with this, E.
Assi et al., review the recent literature about the role of mic-
roglia in inflammatory signaling cascades in brain pathology,
but focusing their paper on the role of sphingolipids in
the inflammatory reaction, which is proposed as a potential
target to control glial-mediated neuroinflammation.
In this context, it is becoming more evident that glial
activation is a critical event that should be targeted to avert
inflammation in the CNS. B. Rocamonde et al. describe, in
an original study, using a rat model of brain injury, that
the reduction of glial activation by lipoic acid underlies the
restorative effects in the brain. F. Cloutier et al. suggest in
an interesting paper that the role of microglia and astro-
cytes during spinal cord injury and repair may be different
depending on the scenario of CNS damage. Authors report,
using a rat model of acute demyelination in dorsal funiculus,
how immunological using anti GalC demyelination triggers
macrophage/microglial cells activation in comparison of a
stab injury. Interestingly, in their model of axon regeneration,
the participation of astrocytes is limited, whereas microglia
and infiltrated macrophages have a prominent role, which
emphasize the potential of targeting microglial cells for
therapeutic purposes.
From this perspective, papers on CNS autoimmunity, MS
and MS’ experimental models have largely contributed to
our special issue. We have compiled extensive reviews and
original papers about the initial immune-pathogenesis of MS
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as well as the immunology and oxidative stress underlying the
disease. R. Bassil et al. provide a comprehensive reassessment
on the important function ofNotch signaling in the activation
of T helper cells in experimental autoimmune encephalitis
(EAE). They propose targeting Notch signaling as a potential
strategy for MS therapy, but they also report the limitations
of this approach due to the wide range of functions of
Notch signaling, suggesting interesting new research avenues.
Herna´ndez-N. Y. Pedro et al. discuss the innate immune
responses occurring during the immune-pathogenesis ofMS,
which are hypothesized as a critical trigger of the chronic
inflammatory response. In line with this, G. G. Ortiz et al.
describe that oxidative stress and inflammation are impor-
tant elements in the self-perpetuation inflammatory/immune
cycle of MS. These pathways may contain targets that could
be promising to avert the inflammatory responses in MS.
Concluding this MS section from a practical point of view,
S. F. Gonc¸alves Zorzella-Pezavento et al contribute to settle
down the potential controversy regarding the tuberculosis
(TB) vaccination protocols, suggesting that TB vaccination
does not trigger or worsen EAE pathology.
Immunotherapy is also an important topic covered by
this special issue. In the CNS, T-lymphocytes infiltrate into
the inflamed brain parenchyma and the manipulation of
different T-cell subpopulations may have beneficial effect on
neurodegenerative disorders and diverse brain injuries. T
cell infiltration is observed in many neurodegenerative dise-
ases including Parkinson’s and Alzheimer’s disease and we
are getting to know more aspects on how T-cells may
affect neurodegeneration [5, 6]. Importantly, immunotherapy
based on targeting T cells (Tregs and Th17 cells) for autoim-
munity disorders and cancer is becoming a rising field of
investigation [7]. However, the precise lymphocyte function
in the damaged brain parenchyma is still poorly understood.
S. Chen et al. propose, in a completed review, that the
modulation of Tregs may have a favorable outcome for stroke
patients.This is based on the fact that Tregs downregulates the
excessive brain immune-reaction, which could be favorable
for tissue restoration. In line with this, M. S. Zaborowski and
Michalak describe how the appearance of paraneoplastic neu-
rological syndromesmay be linkedwith the certain antitumor
responses triggered by T cells. Thus, authors suggest that the
manipulation of specific subpopulation of T cells, pondering
the balance betweenTregs andCTLs through immunotherapy,
could be beneficial for these neurological disorders.
In this context of immunotherapy, the search for antigens
that may trigger autoimmune responses in the brain is a
crucial field of research. The review by A. Seppa¨nen pro-
poses collagen XVII as a candidate antigen. Autoantibodies
against different domains of collagen XVII are found elevated
in serum of patients within a wide range of neurological
disorders as well as in skin autoimmune disorders, sug-
gesting that an autoimmune response may be the common
trigger of those disorders. On the other hand, increas-
ing evidence indicates that immune system dysfunction
may also be underlying a number of psychiatric disorders.
K. Pathmanandavel et al. hypothesize in their thought-
provoking review that some neuronal autoantibodies may
be linked with psychiatric symptoms and could open new
immunomodulatory approaches for neuropsychiatric disor-
ders in the near future.
We scarcely know the factors that trigger CNS diseases.
It is thought that genetic and environmental factors, which
include the exposure to chemical compounds or particular
pathogens, may contribute to the appearance of these disor-
ders. T. T.Win-Shwe et al. discuss an interesting point regard-
ing the immune-related inflammation that environmental
volatile compounds may induce. The review hypothesizes
how environmental volatile elements may affect respiratory
and immune system, having neurological consequences for
the population. On the other hand, T. Hautala et al. report
in our special issue how viruses, in this case Puumala virus, a
northern European type ofHantavirus, are important entities
that may seriously affect the CNS. Other pathogen infections,
such as Trypanosoma brucei, which causes sleeping sickness,
may also cause severe brain damage. Interestingly, D. N.
Maranga et al., members of a research group based in Kenya,
present in our special issue a research study performed in few
monkeys showing that the increase of the proinflammatory
cytokine IL-6 in spinal fluid may be a reliable marker to
manage human African trypanosomiasis in areas where the
diagnostic tools are very limited and derived neurological
consequences are frequent. Lastly, A. P.Herman et al. describe
how the inflammatory-mediated release of cytokines, such as
IL-1𝛽, may have consequences in the hypothalamic neurons
affecting the reproductive system. This highlights that it
is also important to consider the effect that neuroimmune
interactions and neuroinflammationmay have inmany other
systems.
We hope this collection of papers is helpful for readers
to understand better the peculiar relationship between the
immune system and CNS and may be a stimulus to continue
the research on this complex field.
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